AKAP11 and bipolar disorder: Biochemically, AKAP11 interacts with protein kinase A (PKA), a protein that is involved in a variety of biological processes including neuronal plasticity, and with glycogen synthase kinase 3 beta (GSK3β), one of the targets of lithium, a mainstay therapy for bipolar disorder [22–24].